NIDA-41020
SIGMA/N8162 - ≥97% (HPLC), solid
Synonym: 1-
CAS Number: 502486-89-7
Empirical Formula (Hill Notation): C23H24Cl2N4O2
Molecular Weight: 459.37
MDL Number: MFCD08277026
Linear Formula: C23H24Cl2N4O2
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | off-white |
| form | solid |
| InChI | 1S/C23H24Cl2N4O2/c1-15-21 |
| InChI key | KWDBQJRWPWTGPF-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | COc1ccc(cc1)-c2c(C)c(nn2- |
| solubility | DMSO: ~16 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | NIDA-41020 is a CB1 cannabinoid receptor antagonist. NIDA-41020 is structurally similar to Rimonabant, which is currently in clinical development. NIDA-41020 is less lipophilic; developed at NIDA as a potential radioligand for CB1 receptors, Ki = 4.1 nM [in comparison AM 251, AM 281, SR 141716 (Rimonabant) have Ki of 0.6, 4.5 and 1.8 nM respectively]. |
| Biochem/physiol Actions: | NIDA-41020 is a CB1 cannabinoid receptor antagonist. |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H300 - H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P270 - P301 + P310 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 25-36/37/38 |
| Safety Statements | 26-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


